Two announcements signaled expansion of single‑cell capabilities toward clinical and functional genomics. Swedish spinout Epigenovo unveiled its scFFPE‑ATAC assay to profile chromatin accessibility at single‑cell resolution from formalin‑fixed paraffin‑embedded (FFPE) tissue, aiming to unlock archival samples for translational epigenetics. The company is raising funds to commercialize kitted workflows and services. Separately Parse Biosciences and Codebreaker Labs agreed to combine engineered variant libraries with high‑throughput single‑cell transcriptomics to measure how genetic variants alter cell states. The Parse–Codebreaker collaboration targets systematic functional annotation of variants to accelerate genome interpretation, target discovery and AI training for drug discovery.